Viewing nowCombinationDouble Star Tablet 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
TDS Pharm Co., Ltd.

MFDS item code 201900625 · Approved 2019.01.24 · Insurance code 679801760
Treatment of essential hypertension not controlled with monotherapy
This medication effectively lowers blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of either telmisartan or amlodipine. It helps reduce the risk of cardiovascular complications and improve the patient’s health status.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued immediately. Patients with allergies to any components of this medication or similar drugs, those who are pregnant or breastfeeding, and patients with severely impaired liver function should not take this drug. Patients with serious heart or blood pressure problems should also avoid this medication. Patients with certain diseases, such as primary aldosteronism, heart valve disease, or liver disease, should use this drug with caution. Patients with gastrointestinal diseases, kidney diseases, or the elderly should also be careful when taking this medication. Since this drug lowers blood pressure, there is a risk of hypotension, and immediate action should be taken if symptoms appear. Furthermore, there may be a risk of elevated blood potassium levels, so regular blood tests may be necessary. Side effects such as dizziness, drowsiness, and visual disturbances may occur while taking this medication, so caution should be exercised when driving or operating machinery. There may be interactions with other medications, so it is essential to consult with a doctor or pharmacist. In case of overdose, hypotension and heart problems may occur, and immediate medical assistance should be sought. This medication is not recommended for children, and elderly patients should adjust the dosage accordingly. When storing, keep out of reach of children and ensure it is not exposed to moisture.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a special container to protect it from light and air, and it is advisable to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature). Proper storage will help ensure the safety of the medication's effectiveness.
Biconvex oval double tablet in white and light blue color
30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.